A series of recent studies in mice and rats has mapped specific brain circuits that appear to drive chronic pain, identifying precise neural pathways that could eventually become targets for non-opioid therapies. The most detailed of these, published in Nature, traced a complete loop from the spinal cord through several brain regions and back again, showing that this circuit is both necessary and sufficient to sustain pain hypersensitivity after nerve injury or inflammation. Together with complementary findings on insular cortex pathways and thalamic neuron populations, the work offers the clearest picture yet of how the brain locks in persistent pain states, and where future treatments might intervene.
What is verified so far
The central finding comes from a paper in Nature that mapped a multisynaptic loop running from the spinal cord to the thalamus, then to the somatosensory cortex, the lateral superior colliculus, the rostral ventromedial medulla, and back to the spinal cord. Using causal testing in mice, the researchers showed that this closed pain circuit is both necessary and sufficient for chronic mechanical hypersensitization following nerve injury or inflammation. Disrupting any relay in the loop reversed pain-like behavior, while activating it reproduced hypersensitivity even without an injury trigger.
To move beyond a single-article view, a companion analysis in Nature’s news section placed the work in a broader context of efforts to decode how the brain maintains long-lasting pain. That piece emphasized how the loop study combines anatomical tracing, electrophysiology and behavioral testing to link cellular-level changes to whole-animal pain responses, and it underscored that the identified pathway may represent just one component of a larger, distributed network. The news coverage framed these findings as part of a shift from viewing chronic pain as a static injury response to seeing it as an actively maintained brain state, highlighting both the promise and the limits of current circuit-mapping approaches.
A separate line of evidence points to the insular cortex as a critical switching station. A study in The Journal of Neuroscience identified and manipulated a pathway from the caudal granular insular cortex to the somatosensory cortex in rats. That pathway appears to govern the transition from acute pain to lasting allodynia, the condition in which normally harmless touch becomes painful. In experiments described in the journal article (DOI: 10.1523/jneurosci.1306-25.2025), silencing this projection during a critical window after injury prevented the development of chronic hypersensitivity, whereas activating it could prolong pain-like responses.
The insular cortex finding builds on earlier foundational work from the same research lineage. A prior rat study demonstrated that lesioning the caudal granular insular cortex produced long-term relief from neuropathic allodynia, establishing that specific cortical nodes can sustain chronic pain-like states on their own. In that work, animals with targeted damage to this region showed durable reductions in touch-evoked pain behavior without broad motor deficits, suggesting a relatively selective role for this area in maintaining allodynia rather than general sensation. The results, reported in a paper indexed on PubMed, used histology and behavioral assays to link insular damage to reduced neuropathic hypersensitivity.
A third strand of research, published in the Proceedings of the National Academy of Sciences, adds a different dimension by focusing on the emotional component of pain. Researchers at the Salk Institute identified CGRP-expressing thalamic neurons that define a spinothalamic pathway mediating the affective, or emotional and motivational, aspects of pain in mice. This work, available in full through open-access data, separates the sensory experience of pain from the suffering it causes, a distinction with direct implications for treatment design. The Salk team framed these neurons as potential targets for therapies aimed at chronic and affective pain conditions without relying on opioids, emphasizing that modulating this pathway could reduce the “agony” of pain even if basic detection of harmful stimuli remains intact.
Additional research published in Nature by Goldstein and colleagues identified an ensemble of parabrachial neurons unified by NPY receptor Y1 expression. Activity in these neurons increases following injury and predicts coping behavior. Survival-related need states such as hunger, thirst and predator cues suppress sustained pain by inhibiting these neurons through NPY release, revealing a biological mechanism by which the brain prioritizes competing threats over ongoing pain. In behavioral paradigms, animals facing more urgent challenges showed dampened pain responses, and recordings linked this shift to reduced firing in the identified parabrachial population.
Together, these lines of evidence converge on a picture of chronic pain as an actively maintained brain state, supported by specific loops and nodes rather than a diffuse, unspecific response to injury. They also highlight multiple points where intervention might be possible: spinal-thalamic relays, cortical “decision” hubs, affective thalamic neurons, and brainstem circuits that weigh pain against other survival needs.
What remains uncertain
All of these findings rest on animal models. The spino-brain-spinal cord loop was demonstrated in mice. The insular cortex pathway was tested in rats. The CGRP thalamic neuron work also used mice. No human neuroimaging or clinical trial data currently confirm that these same circuits operate identically in people. Rodent pain research has a long history of producing promising leads that fail to translate into effective human therapies, and there is no guarantee these pathways will prove equally central in the far more complex human brain.
The relationship between the different circuits also remains unclear. The Nature paper traces a full loop through the somatosensory cortex. The Journal of Neuroscience study highlights the insular-to-somatosensory connection. The PNAS paper focuses on thalamic relay neurons with a distinct molecular signature. Whether these represent separate mechanisms, overlapping nodes in a single system, or parallel pathways that reinforce each other is not yet established. No published study has integrated these findings into a unified model, and the field lacks comparative data from non-human primates that might bridge the gap between rodent experiments and human relevance.
There are also technical and practical caveats. The loop-mapping study relied heavily on optogenetic and chemogenetic tools to silence or activate specific neuron populations with high precision. The insular work similarly used targeted manipulations that are not currently feasible in people. While viral vectors, deep brain stimulation and focused ultrasound are inching closer to circuit-level interventions in humans, none can yet reproduce the cell-type specificity achieved in these animal experiments. Moreover, access to detailed content from some journals still requires institutional credentials or individual sign-in, as indicated by Nature’s own authentication gateway, which can slow independent verification and secondary analysis by clinicians and researchers outside major centers.
Translation to therapy faces additional hurdles. No regulatory body has weighed in on the feasibility of targeting these pathways for drug development. The institutional press releases from both CU Boulder and the Salk Institute frame the findings in terms of future non-opioid treatments, but neither offers a timeline or identifies a specific drug candidate. The gap between circuit identification in a mouse and a viable human therapy typically spans a decade or more, even when the basic biology is straightforward, and chronic pain is not.
How to read the evidence
The strongest claims in this body of work come from primary peer-reviewed papers that used causal experimental methods, not just correlational imaging. The Nature paper on the spino-brain-spinal cord loop, for instance, did not merely observe which brain regions light up during pain. It systematically disrupted and activated each relay in the circuit to prove necessity and sufficiency, a higher standard of evidence than most pain neuroimaging studies achieve. Similarly, the Journal of Neuroscience experiments on the insular projection used temporally precise silencing and activation to show that manipulating this pathway during a specific post-injury window can alter whether pain becomes chronic.
At the same time, readers should be cautious about extrapolating directly from rodent behavior to human experience. Measures such as paw withdrawal or conditioned place aversion are well-validated proxies for pain in animals, but they cannot capture the full cognitive, social and existential dimensions of human suffering. The PNAS study’s separation of sensory detection from affective distress is an important conceptual advance, yet it remains to be seen how closely mouse avoidance behavior maps onto human reports of anguish or disability.
For now, the most reasonable interpretation is that these studies illuminate plausible mechanisms rather than definitive targets. They show that the brain contains dedicated circuits capable of sustaining pain states, that these circuits can be turned up or down experimentally, and that different components of pain (sensation, emotion, prioritization) may be handled by partially distinct pathways. The findings justify further investment in circuit-level pain research and suggest new hypotheses for human imaging and pharmacology to test.
What they do not yet provide is a ready-made blueprint for new drugs or devices. Any eventual therapy will have to balance efficacy against the risk of dulling necessary protective pain or disrupting other functions handled by the same circuits, such as attention, motivation or threat detection. Until those trade-offs are better understood in people, the new maps of pain circuitry should be seen as promising guides rather than final answers.
More from Morning Overview
*This article was researched with the help of AI, with human editors creating the final content.
